BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE

B. Olivier,; J. Mos,; D.L. Rasmussen,

doi:10.1515/DMDI.1990.8.1-2.31

Home BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE

Article

Licensed

Unlicensed Requires Authentication

BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE

B. Olivier, , J. Mos, and D.L. Rasmussen,

Published/Copyright: June 1, 1990

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information

From the journal Drug Metabolism and Drug Interactions Volume 8 Issue 1-2

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

Olivier,, B., Mos,, J. and Rasmussen,, D.L.. "BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE" Drug Metabolism and Drug Interactions, vol. 8, no. 1-2, pp. 31-84. https://doi.org/10.1515/DMDI.1990.8.1-2.31

Olivier,, B., Mos,, J. & Rasmussen,, D. (). BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE. Drug Metabolism and Drug Interactions, 8(1-2), 31-84. https://doi.org/10.1515/DMDI.1990.8.1-2.31

Olivier,, B., Mos,, J. and Rasmussen,, D. () BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE. Drug Metabolism and Drug Interactions, Vol. 8 (Issue 1-2), pp. 31-84. https://doi.org/10.1515/DMDI.1990.8.1-2.31

Olivier,, B., Mos,, J. and Rasmussen,, D.L.. "BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE" Drug Metabolism and Drug Interactions 8, no. 1-2 (): 31-84. https://doi.org/10.1515/DMDI.1990.8.1-2.31

Olivier, B, Mos, J, Rasmussen, D. BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE. Drug Metabolism and Drug Interactions. ;8(1-2): 31-84. https://doi.org/10.1515/DMDI.1990.8.1-2.31

Copy

Copied to clipboard

BibTeX EndNote RIS

Published Online: 1990-06

You are currently not able to access this content.

Articles in the same Issue

TABLE OF CONTENTS
SERENICS: AN INTRODUCTION
ETHOPHARMACOLOGY: A CREATIVE APPROACH TO IDENTIFICATION AND CHARACTERISATION OF NOVEL PSYCHOTROPICS
BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE
NEUROCHEMICAL PROFILE OF ELTOPRAZINE
DISTRIBUTION OF RADIOACTIVELY LABELLED ELTOPRAZINE IN RAT AND DOG
THE METABOLITE PATTERNS OF ELTOPRAZINE IN MAN, DOG, RAT AND RABBIT
PHARMACOKINETICS OF ELTOPRAZINE IN THE DOG
PHARMACOKINETICS OF ELTOPRAZINE IN HEALTHY SUBJECTS
POSSIBLE CLINICAL APPLICATIONS OF SERENICS AND SOME IMPLICATIONS OF THEIR PRECLINICAL PROFILE FOR THEIR CLINICAL USE IN PSYCHIATRIC DISORDERS

Search journal Search the content of this journal

https://doi.org/10.1515/DMDI.1990.8.1-2.31

Articles in the same Issue

TABLE OF CONTENTS
SERENICS: AN INTRODUCTION
ETHOPHARMACOLOGY: A CREATIVE APPROACH TO IDENTIFICATION AND CHARACTERISATION OF NOVEL PSYCHOTROPICS
BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE
NEUROCHEMICAL PROFILE OF ELTOPRAZINE
DISTRIBUTION OF RADIOACTIVELY LABELLED ELTOPRAZINE IN RAT AND DOG
THE METABOLITE PATTERNS OF ELTOPRAZINE IN MAN, DOG, RAT AND RABBIT
PHARMACOKINETICS OF ELTOPRAZINE IN THE DOG
PHARMACOKINETICS OF ELTOPRAZINE IN HEALTHY SUBJECTS
POSSIBLE CLINICAL APPLICATIONS OF SERENICS AND SOME IMPLICATIONS OF THEIR PRECLINICAL PROFILE FOR THEIR CLINICAL USE IN PSYCHIATRIC DISORDERS